Medtronic hit by defib lead crisis after "very serious" Fidelis recall
This article was originally published in Clinica
Executive Summary
Medtronic's flagging defibrillator business suffered a major setback this week, when the discovery of a potentially fatal defect led to the firm suspending shipments of a best-selling defibrillation lead.